The AMD Experts
We’re on a mission to eliminate blindness caused by age-related macular degeneration (AMD). Our vision is bold but well within reach.
MacuLogix® is a company that equips eye care professionals with the technology, tools, and education needed to help identify and manage AMD patients early, before irreversible vision loss has occurred. We can help you deliver better patient care with the scientifically validated AdaptDx Pro®.
Help us save the eyesight of millions by making early functional testing for AMD a routine part of eye care for your aging patients.
Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.
By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize that what’s good for our patients winds up being good for our practices.
Latest News & Upcoming EventsView More
Dr. Glenn Corbin, one of the earliest adopters of dark adaptation testing in optometric practice, explains how using both structural and functional testing removes the guesswork out of AMD diagnosis and monitoring.
Dr. Glenn Corbin believes eye care providers can diagnose AMD early by implementing protocols that make the transition from suspicion to diagnosis smooth and pleasant for patients. Here’s the protocol used in his practice.
Dr. Claudio Lagunas purchased two AdaptDx Pro devices to keep up with demand. This technology has transformed care in his practice while spurring profitability and allowing his team to make dark adaptation testing the norm, rather than the exception.
Put Our Expertise to Work
Testing with AdaptDx Pro
AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.
Each AdaptDx Pro purchase is supported by our AMD Excellence Program® to help you achieve your patient care and practice revenue goals.